SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Filing Date
Jan 18, 2012
Document Date
Jan 18, 2012
Form Description
Termination of registration under Section 12(g) or suspension of duty to file reports
Filing Group
Other
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC